Archives of General Psychiatry · 1999 · 628 citations · 32 references
Life SciencesNeurosciencePsychiatryClinical NeuroscienceNeurochemistryNeuropsychiatryAmino Acid NeurochemistryDepressive DisordersGabaergic NeurochemistryGabaergic SignalingGlutamatergic NeurochemistryMagnetic Resonance SpectroscopyGabaergic DysfunctionGabaergic DysregulationGabaergic Synaptic DysfunctionMagnetic ResonanceMajor DepressionNeurobiology Of DepressionNeurotransmitter System AlterationsOccipital Cortex
BACKGROUND: Several lines of emerging evidence suggest that dysfunction of gamma-aminobutyric acid (GABA) systems is associated with major depression. However, investigation of this hypothesis is limited by difficulty obtaining noninvasive in vivo measures of brain GABA levels. In this study we used in vivo proton magnetic resonance spectroscopy to investigate the hypothesis that abnormalities in the GABA neurotransmitter system are associated with the neurobiologic processes of depression. METHODS: The GABA levels were measured in the occipital cortex of medication-free depressed patients meeting DSM-IV criteria (n = 14) and healthy control subjects with no history of mental illness (n = 18) using a localized difference editing proton magnetic resonance spectroscopy protocol. An analysis of covariance was employed to examine the effects of depression, sex, and age. RESULTS: The depressed patients demonstrated a highly significant (52%) reduction in occipital cortex GABA levels compared with the group of healthy subjects. While there were significant age and sex effects, there was no interaction of diagnosis with either age or sex. CONCLUSION: This study provides the first evidence of abnormally low cortical GABA concentrations in the brains of depressed patients.
32
Efficacy of Divalproex vs Lithium and Placebo in the Treatment of Mania
C.L. Bowden · JAMA · 1994 · 916 citations
Metabolism and role of glutamate in mammalian brain
Maria Erecińska, Ian A. Silver · Progress in Neurobiology · 1990 · 683 citations · Full text